Impact of GLP-1 and GLP-1 Receptor Agonists on Cardiovascular Risk Factors in Type 2 Diabetes
Year: 2010
Type: article
Source: Current Diabetes Reviews
Authors: Danilo Verge, Ximena Lopez
Institutions: Novo Nordisk Pharma, SA (Spain), Novo Nordisk (Denmark)
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2007217090
